In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm-Reference-Cited by-全球学者库

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm

Published:2020-10-02 Issue:10 Volume:15 Page:e0240149
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Artigas Laura,Coma Mireia,Matos-Filipe Pedro,Aguirre-Plans Joaquim^ORCID,Farrés Judith,Valls Raquel,Fernandez-Fuentes Narcis,de la Haba-Rodriguez Juan,Olvera Alex,Barbera Jose,Morales Rafael,Oliva Baldo^ORCID,Mas Jose Manuel

Funder

Ministerio de Ciencia, Innovación y Universidades

H2020 Marie Skłodowska-Curie Actions

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference97 articles.

1. Shen S, Woo R. Coronavirus incubation could be as long as 27 days, Chinese provincial government says. In: Reuters [Internet]. 2020 [cited 2 Apr 2020]. Available: https://es.reuters.com/article/idUKKCN20G072

2. Centers for Disease Control and Prevention (CDC). Symptoms of Coronavirus Disease 2019 (COVID-19) | CDC. In: Centers for Disease Control and Prevention (CDC) [Internet]. 2020 [cited 2 Apr 2020]. Available: https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html

3. Clinical trials on drug repositioning for COVID-19 treatment.;SG Viveiros Rosa;PAJPH.,2020

4. Hopes rise for coronavirus drug remdesivir;H. Ledford;Nature,2020

5. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing;DE Gordon;Nature,2020

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the antiviral potential of melatonin: A comprehensive systematic review;Reviews in Medical Virology;2023-12-21

2. A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis;Frontiers in Immunology;2023-09-20

3. Polypharmacology guided drug repositioning approach for SARS-CoV2;PLOS ONE;2023-08-09

4. In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression;Frontiers in Neuroscience;2023-06-30

5. Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab;Scientific Reports;2023-06-21